These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4479678)

  • 1. [Therapeutic effect of rifampicin (RFP) on leprosy. I. Clinical effect (observation of twelve months) (author's transl)].
    Repura; 1974; 43(1):8-25. PubMed ID: 4479678
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of rifampicin (RFP) on leprosy. II. On the changes of the morphological index of M. leprae in patients (author's transl)].
    Ozawa T
    Repura; 1974; 43(1):26-34. PubMed ID: 4610308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effect of rifampicin (RFP) on leprosy. III. Histopathological investigation (author's transl)].
    Sasaki N; Kawatsu K
    Repura; 1974; 43(1):35-44. PubMed ID: 4479675
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effect of rifampicin (RFP) on leprosy. IV. Serological examination (author's transl)].
    Abe M; Minagawa F; Yoshino Y
    Repura; 1974; 43(1):45-51. PubMed ID: 4479676
    [No Abstract]   [Full Text] [Related]  

  • 5. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin (RFP) trial in lepromatous leprosy.
    Koticha KK; Pade SS; Chulawala RG; Juwatkar PS
    Lepr India; 1982 Jul; 54(3):441-7. PubMed ID: 6757577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flu like syndrome with rifampicin pulse therapy.
    Parking AA; Shah BH
    Indian J Lepr; 1989 Apr; 61(2):209-10. PubMed ID: 2746030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible acute renal failure due to monthly administration of rifampicin in a leprosy patient.
    Kar HK; Roy RG
    Indian J Lepr; 1984; 56(4):835-9. PubMed ID: 6549453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent rifampicin therapy in lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rifampicin for leprosy: comparative study with several doses and intervals of administration.
    Namba M; Hazama S
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):198. PubMed ID: 945236
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1980 Apr; 55(4):207-14. PubMed ID: 6993746
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of L-tetramisol associated with rifampicin in patients with lepromatous leprosy. L-tetramisol in patients with lepromatous leprosy].
    Galmarini M; Riera CM; Ripoll J; Orozco MA; Katz J
    Med Cutan Ibero Lat Am; 1978; 6(3-4):179-83. PubMed ID: 398916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 16. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospects for leprosy treatment via complexation of rifampicin witH iodide and horse-radish root].
    Maslov AK; Khivrina SA
    Probl Tuberk Bolezn Legk; 2007; (4):25-7. PubMed ID: 17657964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 20. An unusual reaction to rifampicin in a once monthly dose.
    Sule RR
    Lepr Rev; 1996 Sep; 67(3):227-8. PubMed ID: 8885617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.